These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 11740389

  • 1. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
    Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H.
    Transplantation; 2001 Dec 15; 72(11):1787-92. PubMed ID: 11740389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial.
    Midtvedt K, Hartmann A, Holdaas H, Fauchald P.
    Clin Transplant; 2001 Dec 15; 15(6):426-31. PubMed ID: 11737121
    [Abstract] [Full Text] [Related]

  • 4. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients.
    Asberg A, Midtvedt K, Vassbotn T, Hartmann A.
    Nephrol Dial Transplant; 2001 Jul 15; 16(7):1465-70. PubMed ID: 11427642
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug 15; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
    Campo C, Garcia-Vallejo O, Barrios V, Lahera V, Manero M, Esteban E, Rodicio JL, Ruilope LM.
    J Hypertens; 1997 Dec 15; 15(12 Pt 2):1803-8. PubMed ID: 9488243
    [Abstract] [Full Text] [Related]

  • 8. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G, Feehally J, Elliott HL, Griffin P, Moore RJ, Olubodun JO, Wilkinson R.
    Nephrol Dial Transplant; 1998 Oct 15; 13(10):2612-6. PubMed ID: 9794569
    [Abstract] [Full Text] [Related]

  • 9. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G, Martinoli C, Viazzi F, Ravera M, Parodi D, Ratto E, Vettoretti S, Tomolillo C, Derchi LE, Deferrari G, Pontremoli R.
    Nephron; 2002 Feb 15; 90(2):169-73. PubMed ID: 11818701
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.
    Diabetes; 1997 Jul 15; 46(7):1182-8. PubMed ID: 9200654
    [Abstract] [Full Text] [Related]

  • 13. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 14. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.
    Diabetes; 1997 Mar 25; 46(3):481-7. PubMed ID: 9032106
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the antihypertensive effect of lisinopril compared with nifedipine in patients with mild to severe essential hypertension.
    Eber B, Brussee H, Rotman B, Kramer R, Klein W.
    Angiology; 1992 Jun 25; 43(6):482-9. PubMed ID: 1317687
    [Abstract] [Full Text] [Related]

  • 16. Use of calcium-channel blockers in pediatric renal transplant recipients.
    Silverstein DM, Palmer J, Baluarte HJ, Brass C, Conley SB, Polinsky MS.
    Pediatr Transplant; 1999 Nov 25; 3(4):288-92. PubMed ID: 10562973
    [Abstract] [Full Text] [Related]

  • 17. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH.
    J Hum Hypertens; 1996 Mar 25; 10(3):185-92. PubMed ID: 8733038
    [Abstract] [Full Text] [Related]

  • 18. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM, Soufer R, Hoffer P, Wackers FJ, Black HR.
    Am J Hypertens; 1996 Jun 25; 9(6):598-606. PubMed ID: 8783785
    [Abstract] [Full Text] [Related]

  • 19. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants.
    Mourad G, Ribstein J, Mimran A.
    Kidney Int; 1993 Feb 25; 43(2):419-25. PubMed ID: 8382753
    [Abstract] [Full Text] [Related]

  • 20. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG, Kramer HJ.
    J Hum Hypertens; 1994 Oct 25; 8(10):777-80. PubMed ID: 7837215
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.